Research interest
I am part of a group, led by Shahid Khan, who is interested in generated genetically attenuated parasites, with an end aim to producing a whole organism anti-malaria vaccine. It has been shown many decades ago that whole malaria parasite irradiation can indeed confer immunological protection if the parasite can travel from the insect host to the human liver, however, generating reproducible and reagent quantities of parasite material has proved arduous. The group’s work hopes to emulate and improve upon previous findings by discreetly targeting liver stage specific genes – this approach has already been fruitful with a number of genes in house that show good vaccine potential, however, with these reagents some parasites were still able to complete the liver stage of the malaria lifecycle and so produce an infection; our aim is to generate a parasite that is completely blocked in the liver, and also provides immunological protection.
Background: Prior to my position at LUMC I was involved in many aspects of protein catabolism in parasitic organisms. I was principally interested in parasite peptidase biochemistry, particularly in the identification, characterization and biological validation of parasite enzymes as rational targets for selective chemotherapeutic intervention. My research interests have led me to work with several parasitic protozoa and helminths, including, malaria (see The Synaptic Leap ), Giardia, Cryptosporidium, Entamoeba,Trypanosoma, Leishmania and numerous parasitic nematodes and flukes. Proteases of interest were cloned and heterologously expressed to generate reagent quantities of active enzyme for use in substrate and inhibitor screens as well as crystallography. Specific inhibitors or probes can subsequently be used to delineate the discrete in vivo biological function of the protease of interest. In addition to the aforementioned area of research – I was also very interested in the detailed chemical mechanism of substrate and inhibitor binding and hydrolysis- which provide detailed valuable insights in how drugs interact with the enzyme’s active site and so aid the design of more potent and selective anti-parasite biocides.